Avalo Therapeutics Inc (AVTX)
Healthcare
Biotechnology
18.30 $
-5.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Avalo Therapeutics Inc (AVTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -51 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -16 | -10 | -15 | 13 | -3.1 | -19 | -41 | -71 | -27 | -31 | -49 | -51 | |
| 0.0 | 0.0 | 0.0 | 0.4 | 4.6 | 3.9 | 1.8 | 1.7 | 0.2 | 0.2 | 0.2 | 0.3 | |
| 1.1 | 0.4 | 1.7 | 1.2 | 2.4 | 2.5 | 6.8 | 8.2 | 7.6 | 3.5 | 5.9 | 14 | |
| – | – | – | 0.5 | 26 | -2.5 | 26 | 8.2 | – | – | – | – | |
| -0.4 | 0.9 | 0.1 | -0.5 | 8.7 | -2.0 | -4.4 | 2.8 | 4.8 | -9.2 | -4.7 | 3.8 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.6 | 0.3 | 0.1 | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | -19 | 0.9 | -0.4 | 11 | -0.1 | -0.1 | -0.1 | 0.4 | -82 | |
| – | 0.0 | – | – | – | 1.1 | – | 33 | 15 | – | – | – | |
| – | 0.0 | – | – | – | 0.0 | -0.1 | 0.4 | 0.1 | 0.1 | 0.1 | 0.0 | |
| – | – | – | -2.4 | -0.3 | -0.3 | 33 | 33 | -15 | -21 | 0.0 | – | |
| 24 | 20 | -1.4 | 3.7 | 10 | 13 | 45 | 107 | -15 | 25 | 176 | 15 | |
| 8.3 | 9.4 | -16 | -2.7 | 8.1 | -7.0 | 15 | 36 | -42 | -5.8 | 127 | -119 | |
| -16 | -10 | -15 | 12 | -3.7 | -19 | -41 | -71 | -27 | -31 | -49 | -51 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.